The Global Isothermal Nucleic Acid Amplification Technology Market reached about US$ 4.53 billion in 2023 and is projected to grow to around US$ 8.91 billion by 2031. This represents a compound annual growth rate (CAGR) of 11.1% from 2024 to 2031.
The growth is fueled by the rising use of rapid molecular diagnostic tools, an increase in infectious and chronic disease cases, and...
The Global Cytokine Market reached US$ 72.3 billion in 2022 and is projected to grow to US$ 132.2 billion by 2030, with a CAGR of 7.6% from 2023 to 2030.
Cytokines are signaling proteins that are vital for managing immune responses and inflammation. They play a key role in developing targeted therapies for autoimmune diseases, cancer, and infections. The growth of this market is fueled...
The Global Cardiac Troponin Market reached US$ 4.19 billion in 2023 and is expected to grow to US$ 9.56 billion by 2031. This growth represents a CAGR of 11.2% from 2024 to 2031.
The increase is driven by the rising prevalence of cardiovascular diseases worldwide and the growing demand for faster and more sensitive diagnostic tests. Innovations in troponin assays, such as...
The Global Non-Opioid Pain Treatment Market is expected to grow at an annual rate of about 8% during the period from 2024 to 2031. The market is projected to increase from around USD 44.39 billion in 2024 to about USD 91.74 billion by 2031.
This growth is fueled by the rising number of chronic pain conditions like arthritis, cancer pain, and neuropathic pain, along with a greater...
The Global Radiofrequency Ablation Devices Market reached $5.63 billion in 2024 and is projected to grow to $13.54 billion by 2033, with a CAGR of 10.7% from 2025 to 2033.
This growth is mainly driven by the rising cases of chronic pain, cancer, and cardiac arrhythmias, along with the increasing demand for minimally invasive treatment methods. Improvements in radiofrequency ablation...
The Global Tyrosine Kinase Inhibitors market reached US$ 51.03 billion in 2023, increased to US$ 53.99 billion in 2024, and is expected to hit US$ 93.97 billion by 2033, growing at a CAGR of 6.4% from 2025 to 2033.
This growth is driven by the rising cancer rates, greater use of precision oncology, and ongoing development in targeted drug creation. The increasing adoption of personalized...
The Global Chronic Disease Management Market was valued at US$ 4.8 billion in 2022 and is projected to grow to US$ 14.6 billion by 2031, with a compound annual growth rate (CAGR) of 11.4% from 2024 to 2031.
This growth is attributed to the rising number of chronic diseases like cardiovascular disorders, diabetes, and respiratory conditions, as well as an increasing elderly population...
The Global Optic Neuritis Treatment Market was valued at US$ 204.9 million in 2022. It is expected to grow to US$ 302.7 million by 2030, with a compound annual growth rate (CAGR) of about 5% during the forecast period from 2023 to 2030.
This growth is driven by the rising incidence of multiple sclerosis and other autoimmune disorders that lead to optic neuritis. Improvements in treatment...
The Global Extracorporeal Membrane Oxygenation (ECMO) Market was valued at about USD 308 million in 2023. It is expected to grow to roughly USD 446 million by 2030, with a CAGR of around 5.5% during the forecast period from 2023 to 2030.
This growth comes from the rising rates of cardiopulmonary and respiratory diseases, increased use of ECMO technology in critical care, and improvements...
The Global Voice Prosthesis Devices Market was valued at US$ 579 million in 2023 and is projected to reach US$ 1.2 billion by 2030, growing at a CAGR of about 10.4% during the forecast period from 2023 to 2030.
This growth is fueled by the rising rates of laryngeal cancer, the increasing number of laryngectomy surgeries, and a growing awareness of voice rehabilitation options....
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek